“My No. 1 goal is to stop this insidious drug”

“The problem is that the people that prescribe this, as a general rule, are cardiologists and family practitioners,” said Dr. Mark L. Mosley, director of the emergency room at Wesley Medical Center in Wichita, Kan. “The people that see the harm are your E.R. docs and your trauma docs.”

From Today’s New York Times:

Dr. Bryan A. Cotton, a trauma surgeon in Houston, had not heard much about the new anticlotting drug Pradaxa other than the commercials he had seen during Sunday football games.

Then people using Pradaxa started showing up in his emergency room. One man in his 70s fell at home and arrived at the hospital alert and talking. But he rapidly declined. “We pretty much threw the whole kitchen sink at him,” recalled Dr. Cotton, who works at Memorial Hermann-Texas Medical Center. “But he still bled to death on the table.”

Unlike warfarin, an older drug, there is no antidote to reverse the blood-thinning effects of Pradaxa.


Walter Daumler, who lives in Wisconsin, said he watched his 78-year-old sister, Doris, bleed to death in May. Mr. Daumler  has hired a lawyer and is considering suing. He said doctors told him that because Doris was on Pradaxa, there was nothing they could do.

“My No. 1 goal is to stop this insidious drug,” Mr. Daumler said. “To get this off the market, so others will not undergo or witness what I saw.”

Continue reading the full story here: http://www.nytimes.com/2012/11/03/business/a-rising-anti-stroke-drug-is-tied-to-risk-of-bleeding-deaths.html?_r=0

Tagged with:

2 Responses to ““My No. 1 goal is to stop this insidious drug””

  1. Over the past 10 years, I have challenged the evidence basis for using warfarin and other anticoagulant drugs for atrial fibrillation, deep venous thrombosis and 28 other medical indications. My published peer-reviewed journal articles have not been rebutted by anticoagulation experts in the FDA and academia. My challenges to anticoagulants have been ignored. The comparator drug that the FDA used to base the approval of Pradaxa is itself unsafe and ineffective. Worldwide, there are about 100,000 unnecessary bleeding deaths per year from anticoagulant drugs.

    You can find my peer reviewed medical publications on Pub Med.

    Good luck in stopping an epidemic that pays drug companies and medical providers over $25 billion per year in the USA.

    David K. Cundiff, MD

  2. admin says:

    Thank you David. Do you have a link to your study?

Leave a Reply


Anti-Spam Protection by WP-SpamFree

Follow Us on:

Contact Us

Privacy Policy

Please click here to view our privacy policy.